Correction: Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics
Main Authors: | Suvi Kalliokoski, Ana-Marija Sulic, Ilma R. Korponay-Szabó, Zsuzsa Szondy, Rafael Frias, Mileidys Alea Perez, Stefania Martucciello, Anne Roivainen, Lauri J. Pelliniemi, Carla Esposito, Martin Griffin, Daniele Sblattero, Markku Mäki, Katri Kaukinen, Katri Lindfors, Sergio Caja |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888306/?tool=EBI |
Similar Items
-
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.
by: Suvi Kalliokoski, et al.
Published: (2013-01-01) -
Correction: Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis and in Mice by Interfering with Endothelial Cell Dynamics.
by: Suvi Kalliokoski, et al.
Published: (2014-01-01) -
Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.
by: Cristina Antonella Nadalutti, et al.
Published: (2013-01-01) -
Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge
by: Hanna Sankari, et al.
Published: (2020-02-01) -
The microbiota as a component of the celiac disease and non-celiac gluten sensitivity
by: Lotta Nylund, et al.
Published: (2016-04-01)